26th Hohenheim Consensus Conference, September 11, 2010 Scientific substantiation of health claims: Evidence-based nutrition

Nutrition

Volumn 27, Issue 10 SUPPL., 2011, Pages

  Biesalski, Hans Konrad ^a   Aggett, Peter J ^b   Anton, Robert ^c   Bernstein, Paul S ^d   Blumberg, Jeffrey ^e   Heaney, Robert P ^f   Henry, Jeya ^g   Nolan, John M ^h   Richardson, David P ⁱ   van Ommen, Ben ^j   Witkamp, Renger F ^k   Rijkers, Ger T ^l,n   Zöllner, Iris ^m  

^a UNIVERSITY OF HOHENHEIM   (Germany)

^b LANCASTER UNIVERSITY   (United Kingdom)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e TUFTS UNIVERSITY   (United States)

^f CREIGHTON UNIVERSITY   (United States)

^g OXFORD BROOKES UNIVERSITY   (United Kingdom)

^h South East Technological University   (Ireland)

ⁱ DPR Nutrition Limited   (United Kingdom)

^j TNO   (Netherlands)

^k WAGENINGEN UNIVERSITY   (Netherlands)

^l UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^m Baden Wuerttemberg State Health Office   (Germany)

ⁿ ST ANTONIUS HOSPITAL   (Netherlands)

more..

Author keywords

Clinical trials; Health claim; Micronutrients; Nutrition; Regulation

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE; CALCIUM; CARBOHYDRATE; CAROTENOID; CYANOCOBALAMIN; FOLIC ACID; INFLUENZA VACCINE; IRON; NICOTINIC ACID; PNEUMOCOCCUS VACCINE; PROBIOTIC AGENT; PYRIDOXINE; RETINOL; RIBOFLAVIN; THIAMINE; TRACE ELEMENT; ZINC;

ADAPTIVE IMMUNITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELLULAR IMMUNITY; DIETARY INTAKE; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; GASTROINTESTINAL INFECTION; HEALTH INSURANCE; HUMAN; IMMUNE SYSTEM; INFLUENZA; INNATE IMMUNITY; INTESTINE FUNCTION; METHODOLOGY; NONHUMAN; NUTRITION; OBSERVATIONAL STUDY; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT INFECTION; RETINA MACULA AGE RELATED DEGENERATION; VACCINATION; VALIDATION PROCESS; WELLBEING; WORLD HEALTH ORGANIZATION;

CAUSALITY; CONGRESSES AS TOPIC; CONSENSUS; DIETARY CARBOHYDRATES; EVIDENCE-BASED MEDICINE; FOOD; GUIDELINES AS TOPIC; HEALTH; HUMANS; MACULAR DEGENERATION; META-ANALYSIS AS TOPIC; MICRONUTRIENTS; NUTRITIONAL STATUS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN A;

EID: 80052751961     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.04.002     Document Type: Article

References (79)

1. Diplock A.T., Aggett P.J., Ashwell M., Bornet F., Fern E.B., Roberfroid M.B. Scientific concepts of functional foods in Europe. Consensus document. Br J Nutr 1999, 81(suppl 1):S1-S27.
2. Richardson D.P., Affertsholt T., Asp N.G., Bruce A., Grossklaus R., Howlett J., et al. PASSCLAIM-synthesis and review of existing processes. Eur J Nutr 2003, 42(suppl 1):I96-I111.
3. Hill A.B. The environment and disease: association or causation?. Proc R Soc Med 1965, 58:295-300.
4. Aggett P.J., Antoine J.M., Asp N.G., Bellisle F., Contor L., Cummings J.H., et al. PASSCLAIM: consensus on criteria. Eur J Nutr 2005, 44(suppl 1):i5-i30.
5. Identifying the environmental causes of disease: how should we decide what to believe and when to take action? Report synopsis 2007, Academy of Medical Sciences, Academy of Medical Science, London, p. 144.
6. Blumberg J., Heaney R.P., Huncharek M., Scholl T., Stampfer M., Vieth R., et al. Evidence-based criteria in the nutritional context. Nutr Rev 2010, 68:478-484.
7. Howick J., Glasziou P., Aronson J.K. The evolution of evidence hierarchies: what can Bradford Hill's 'guidelines for causation' contribute?. J R Soc Med 2009, 102:186-194.
8. Howick J., Glasziou P., Aronson J.K. Evidence-based mechanistic reasoning. J R Soc Med 2010, 103:433-441.
9. Ward A.C. The role of causal criteria in causal inferences: Bradford Hill's "aspects of association." Epidemiol Perspect Innov 2009, 6:2.
10. Phillips C.V., Goodman K.J. The missed lessons of Sir Austin Bradford Hill. Epidemiol Perspect Innov 2004, 1:3.
11. Maxwell J.A. Using qualitative methods for causal explanation. Field Methods 2004, 16:243-264.
12. Diet, nutrition and the prevention of chronic diseases: report of a joint FAG/WHO expert consultation. WHO technical report series 916 2004, World Health Organisation, World Health Organisation, Geneva.
13. Food, nutrition and the prevention of cancer: a global perspective 1997, World Cancer Research Fund/American Institute for Cancer Research, World Cancer Research Fund/American Institute for Cancer Research, Washington, DC.
14. The Netherlands Ministry of Health. Netherlands proposal for a systematic approach for a generic list of health claims. VWA (Dutch Food Authority) Nutrition Centre. 2004.
15. EMEA Working Party on Herbal Medicinal Products. Final concept paper on the implementation of different levels of scientific evidence in core-data for herbal drugs. EMEA/CPMP/HMPWP/1156/03. London; March 3, 2004.
16. Höfler M. The Bradford Hill considerations on causality: a counterfactual perspective. Emerg Themes Epidemiol 2005, 2:11.
17. World Health Organization. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference. 1946.
18. Gallagher A., Meijer G., Richardson D., Rondeau V., Skarp M., Stasse-Wolthuis M., et al. A standardised approach towards PROving the efficacy of foods and food constituents for health CLAIMs (PROCLAIM): providing guidance. Br J Nutr 2011, (in press).
19. What is health? The ability to adapt. Lancet 2009, 373:781.
20. van Ommen B., Fairweather-Tait S., Freidig A., Kardinaal A., Scalbert A., Wopereis S. A network biology model of micronutrient related health. Br J Nutr 2008, 99:S72-S80.
21. van Ommen B., Keijer J., Heil S.G., Kaput J. Challenging homeostasis to define biomarkers for nutrition related health. Mol Nutr Food Res 2009, 53:795-804.
22. Congdon N.G., Friedman D.S., Lietman T. Important causes of visual impairment in the world today. JAMA 2003, 290:2057-2060.
23. Bunce C., Wormald R. Causes of blind certifications in England and Wales: April 1999-March 2000. Eye (Lond) 2008, 22:905-911.
24. Bandello F., Lafuma A., Berdeaux G. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity. Invest Ophthalmol Vis Sci 2007, 48:96-103.
25. Tomany S.C., Wang H.J., van Leeuwen R., Klein R., Mitchell P., Vingerling J.R., et al. Risk factors for incident age-related macular degeneration-pooled findings from 3 continents. Ophthalmology 2004, 111:1280-1287.
26. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001, 119:1417-1436. AREDS (Age-Related Eye Disease Study) Research Group.
27. Albanes D., Heinonen O.P., Taylor P.R., Virtamo J., Edwards B.K., Rautalahti M., et al. Alpha-tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 1996, 88:1560-1570.
28. Omenn G.S., Goodman G.E., Thornquist M.D., Balmes J., Cullen M.R., Glass A., et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996, 334:1150-1155.
29. Loane E., Kelliher C., Beatty S., Nolan J.M. The rationale and evidence base for a protective role of macular pigment in age-related maculopathy. Br J Ophthalmol 2008, 92:1163-1168.
30. Bone R.A., Landrum J.T., Hime G.W., Cains A., Zamor J. Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci 1993, 34:2033-2040.
31. Neuringer M., Johnson E.J., Snodderly D.M., Sandstrom M.M., Schalch W. Supplementation of carotenoid-depleted rhesus monkeys with lutein or zeaxanthin: effects on serum and adipose tissue carotenoids and macular pigment. Invest Ophthalmol Vis Sci 2001, 42:1209.
32. Li B., Ahmed F., Bernstein P.S. Studies on the singlet oxygen scavenging mechanism of human macular pigment. Arch Biochem Biophys 2010, 504:56-60.
33. EU Food Information Council. Vitamins: what they do and where to find them 2008. Available at: Accessed June 10, 2011. http://www.eufic.org/article/en/expid/miniguide-vitamins/.
34. Richer S., Stiles W., Statkute L., Pulido J., Frankowski J., Rudy D., et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry 2004, 75:216-230.
35. Jenkins D.J., Wolever T.M., Taylor R.H., Barker H.M., Fielden H., Baldwin J.M., et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981, 34:362-366.
36. Brand-Miller J., Hayne S., Petocz P., Colagiuri S. Low-glycemic index diets in the management of diabetes: a meta-analysis of randomised controlled trials. Diabetes Care 2003, 26:2261-2267.
37. Brand-Miller J.C., Stockmann K., Atkinson F., Petocz P., Denyer G. Glycemic index, postprandial glycemia, and the shape of the curve in healthy subjects: analysis of a database of more than 1,000 foods. Am J Clin Nutr 2009, 89:97-105.
38. Bjørnholt J.V., Erikssen G., Aaser E., Sandvik L., Nitter-Hauge S., Jervell J., et al. Fasting blood glucose: an underestimated risk factor for cardiovascular death. Diabetes Care 1999, 22:45-49.
39. Blood glucose and risk of cardiovascular disease in the Asia Pacific region. Diabetes Care 2004, 27:2836-2842. Asia Pacific Cohort Studies Collaboration.
40. Albers R., Antoine J.M., Bourdet-Sicard R., Calder P.C., Gleeson M., Lesourd B., et al. Markers to measure immunomodulation in human nutrition intervention studies. Br J Nutr 2005, 94:452-481.
41. Berth M., Delanghe J., Langlois M., De Buyzere M. Reference values of serum IgA subclasses in Caucasian adults by immunonephelometry. Clin Chem 1999, 45:309-310.
42. Yel L. Selective IgA deficiency. J Clin Immunol 2010, 30:10-16.
43. Rijkers G.T., Bengmark S., Enck P., Haller D., Herz U., Kalliomaki M., et al. Guidance for substantiating the evidence for beneficial effects of probiotics: current status and recommendations for future research. J Nutr 2010, 140. 671S-6S.
44. Wolvers D., Antoine J.M., Myllyluoma E., Schrezenmeir J., Szajewska H., Rijkers G.T. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of infections by probiotics. J Nutr 2010, 140:698S-712S.
45. de Vrese M., Winkler P., Rautenberg P., Harder T., Noah C., Laue C., et al. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial. Clin Nutr 2005, 24:481-491.
46. Turner R.B., Bauer R., Woelkart K., Hulsey T.C., Gangemi J.D. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med 2005, 353:341-348.
47. Boge T., Rémigy M., Vaudaine S., Tanguy J., Bourdet-Sicard R., van der Werf S. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 2009, 27:5677-5684.
48. Damen J.E. Harmonization of requirements for influenza virus vaccines: the first year's experience with the EEC guideline. Biologicals 1993, 21:179-182.
49. Feavers I, Knezevic I, Powell M, Griffiths E; WHO Consultation on Serological Criteria for Evaluation and Licensing of New Pneumococcal Vaccines. Challenges in the evaluation and licensing of new pneumococcal vaccines, 7-8 July 2008, Ottawa, Canada. Vaccine 2009;27:3681-8.
50. Kennedy E., Meyers L. Dietary Reference Intakes: development and uses for assessment of micronutrient status of women-a global perspective. Am J Clin Nutr 2005, 81:1194S-1197S.
51. Calvo M.S., Whiting S.J. Overview of the proceedings from Experimental Biology 2004 symposium: vitamin D insufficiency: a significant risk factor in chronic diseases and potential disease-specific biomarkers of vitamin D sufficiency. J Nutr 2005, 135:301-303.
52. Institute of Medicine (IOM). Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academic Press; 2011. Available at: Accessed June 10, 2011. http://www.ilsi.org/Europe/Publications/Beyond%20PASSCLAIM%20Report%202010.pdf.
53. Dalle-Donne I., Rossi R., Colombo R., Giustarini D., Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem 2006, 52:601-623.
54. Fenech M., Baghurst P., Luderer W., Turner J., Record S., Ceppi M., Bonassi S. Low intake of calcium, folate, nicotinic acid, vitamin E, retinol, beta-carotene and high intake of pantothenic acid, biotin and riboflavin are significantly associated with increased genome instability-results from a dietary intake and micronucleus index survey in South Australia. Carcinogenesis 2005, 26:991-999.
55. Blount B.C., Mack M.M., Wehr C.M., MacGregor J.T., Hiatt R.A., Wang G., et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci U S A 1997, 94:3290.
56. Everson R.B., Wehr C.M., Erexson G.L., MacGregor J.T. Association of marginal folate depletion with increased human chromosomal damage in vivo: demonstration by analysis of micronucleated erythrocytes. J Natl Cancer Inst 1988, 80:525-529.
57. Heddle J.A., Fenech M., Hayashi M., MacGregor J.T. Reflections on the development of micronucleus assays. Mutagenesis 2011, 26:3-10.
58. Schneider M., Diemer K., Engelhart K., Zankl H., Trommer W.E., Biesalski H.K. Protective effects of vitamins C and E on the number of micronuclei in lymphocytes in smokers and their role in ascorbate free radical formation in plasma. Free Radic Res 2001, 34:209-219.
59. Hartwig A. Role of magnesium in genomic stability. Mutat Res 2001, 475:113-121.
60. AFSSA (Agence Française de Sécurité Sanitaire des Aliments). Framework for the evaluation of the safety, the effect and the claims of foodstuffs made from plants for the human diet 2003. Available at: Accessed June 10, 2011. http://www.afssa.fr/Documents/NUT-Ra-Plantes.pdf.
61. Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004 amending Directive 2001/83/EC on the community code relating to medicinal products for human use. Off J Eur Union 2004, European Union, L136/34.
62. Corrigendum to Regulation (EC) No 1924/2006 of the European Parliament and of the Council of 20 December 2006 on nutrition and health claims made on foods. Off J Eur Union 2006, European Union, L12/3.
63. Beyond passclaim-guidance to substantiate health claims on foods. ILSI Europe report series 2010, International Life Science Institute, International Life Science Institute, Brussels.
64. Polya G. Biochemical targets of plant bioactive compounds: a pharmacological reference guide to sites of action and biological 2003, New York: CRC Press.
65. Council of Europe. Homeostasis, a practical tool to distinguish between food supplements and medicines 2006. Available at: Accessed June 10, 2011. http://www.coe.int/t/e/social_cohesion/soc-sp/Homeostasis%20(2).pdf.
66. Ethnobotany in the new Europe: people, health and wild plant resources 2010, Berghahn Books, Oxford. M. Pardo-de-Santayana, A. Pieroni, R.K. Puri (Eds.).
67. Marles R. Aboriginal plant use in Canada's northwest boreal forest 1999, UTP, Toronto.
68. Bao Y., Fenwick R. Phytochemicals in health and disease, Institute of Food Research 2004, Marcel Dekker, Norwich, UK.
69. Surh Y.J. Dietary modulation of cell signaling pathways 2009, CRC Press (Taylor & Francis Group), Boca Raton, London, New York.
70. World Health Organisation. WHO monographs on selected medicinal plants. Volumes 1-4. Geneva: World Health Organisation; 1999-2009.
71. Teuscher E., Anton R., Lobstein A. Plantes aromatiques: épices, aromates, condiments et leurs huiles essentielles 2005, Éditions Tec & Doc Lavoisier, Paris, Paris. 1st ed.
72. Frohne D., Pfänder H.J., Anton R. Plantes à risques. Un ouvrage destiné aux pharmaciens, médecins, toxicologues et biologistes 2009, Éditions Tec & Doc Lavoisier, Paris. 1st ed.
73. Elliott R., Pico C., Dommels Y., Wybranska I., Hesketh J., Keijer J. Nutrigenomic approaches for benefit-risk analysis of foods and food components: defining markers of health. Br J Nutr 2007, 98:1095-1100.
74. Nakatsuji H., Kishida K., Kitamura T., Nakajima C., Funahashi T., Shimomura I. Dysregulation of glucose, insulin, triglyceride, blood pressure, and oxidative stress after an oral glucose tolerance test in men with abdominal obesity. Metabolism 2010, 59:520-526.
75. van Ommen B., Keijer J., Kleemann R., Elliott R., Drevon C.A., McArdle H., et al. The challenges for molecular nutrition research 2: quantification of the nutritional phenotype. Genes Nutr 2008, 3:51-59.
76. Shaham O., Wei R., Wang T.J., Ricciardi C., Lewis G.D., Vasan R.S., et al. Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity. Mol Syst Biol 2008, 4:214.
77. Spegel P., Danielsson A.P.H., Bacos K., Nagorny C.L.F., Moritz T., Mulder H., Filipsson K. Metabolomic analysis of a human oral glucose tolerance test reveals fatty acids as reliable indicators of regulated metabolism. Metabolomics 2009, 6:56-66.
78. Zhao X., Peter A., Fritsche J., Elcnerova M., Fritsche A., Häring H.U., et al. Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?. Am J Physiol Endocrinol Metab 2009, 296:E384-E393.
79. Albers R., van der Wielen R.P., Brink E.J., Hendriks H.F., Dorovska-Taran V.N., Mohede I.C. Effects of cis-9, trans-11 and trans-10, cis-12 conjugated linoleic acid (CLA) isomers on immune function in healthy men. Eur J Clin Nutr 2003, 57:595-603.